Coronary Artery Bypass Grafts Market Size and Share Forecast Outlook 2025 to 2035

The global coronary artery bypass grafts market is projected to be valued at USD 18.7 billion in 2025 and is expected to reach USD 24.8 billion by 2035, registering a CAGR of 2.9%. This market is currently experiencing steady expansion driven by the rising global burden of coronary artery disease and increased adoption of minimally invasive and robotic-assisted techniques.

Coronary Artery Bypass Grafts Market

Metric Value
Industry Size (2025E) USD 18.7 billion
Industry Value (2035F) USD 24.8 billion
CAGR (2025 to 2035) 2.9%

Over the next few years, growth will be underpinned by accelerated deployment of next‑generation grafts and enhanced OPCAB (off‑pump) procedures improving patient outcomes. Surge in market penetration as hospitals invest in advanced cardiac infrastructure, supported by government‑led cardiovascular disease initiatives and expanded health insurance access.

Industry leaders such as Medtronic Plc., Terumo Corporation, Edwards Lifesciences, Getinge AB, and Genesee Biomedical continue to dominate through focused R&D on minimally invasive platforms, hybrid operating systems with development of advanced graft materials. These companies are expanding their influence by forging strategic collaborations integrating AI‑enabled intraoperative tools, and launching training programs to enhance OPCAB technique adoption.

In 2025, AMT Medical B.V., announced a USD 25 million Series B financing round led by Bender Analytical Holding B.V. (BAH). The funding accelerates the development of AMT’s ELANA® Heart Bypass System, a minimally invasive solution designed to replace traditional open-heart bypass surgery, ultimately leading to robot-assisted keyhole surgery compatible with surgical robots from industry leaders.

“This financing validates our mission to make open-heart bypass obsolete. By enabling same-day discharge bypass procedures, we’re not just improving outcomes – we’re redefining cardiovascular care.” Said Rutger Tulleken, CEO & Co-Founder of AMT Medical.

North America maintains leadership within the CABG market, driven by high procedural volumes and advanced reimbursement frameworks. Key factors influencing growth includes widespread integration of robotic-assisted and OPCAB procedures, supported by centres of excellence in hybrid cardiac operating rooms.

Innovators such as Medtronic and Genesee Biomedical are actively collaborating with integrated health systems to pilot AI‑guided graft selection and 3D‑printed bio grafts. This region also benefits from strong insurer and Medicare support for novel CABG technologies, accelerating clinical adoption.

Europe is embracing minimally invasive CABG, particularly in Germany, France, and Nordic countries, where hybrid ORs and robot‑assisted systems have seen accelerated diffusion. Regulatory frameworks like the EU MDR are incentivizing adoption of bioengineered and drug‑eluting grafts, especially in tertiary cardiac centres.

Partnerships between device manufacturers and public healthcare systems are rolling out pilot programs for OPCAB and arterial graft technologies. Moreover, Europe’s emphasis on post‑operative outcomes has led to expanded use of AI‑driven tele‑monitoring models, reducing readmission rates and enhancing patient throughput.

Analyzing Coronary Artery Bypass Grafts Market by Top Investment Segments

Off-pump CABG Leads the Market Due to Reduced Surgical Trauma and Improved Patient Recovery

Off-pump CABG has been observed to dominate the market in 2025, accounting for approximately 51.8% of the total revenue share. Its growth has been attributed to advancements in beating-heart surgical techniques that eliminate the need for cardiopulmonary bypass, thereby reducing operative risks.

Coronary Artery Bypass Grafts Market By Technology

The segment’s expansion has been driven by its association with lower post-operative complications, shortened hospital stays, and improved long-term outcomes, particularly in elderly and comorbid populations. Supportive training programs for surgeons and favorable clinical outcomes reported in comparative studies have reinforced its adoption across high-volume cardiac centers. Furthermore, innovation in stabilizing instruments and imaging-guided grafting tools has made the procedure more accessible.

Single CABG Surgery Dominates Due to Early Detection and Increased Focus on Preventive Interventions

Single CABG surgery has been found to hold a 34.6% share in the global market by 2025, driven by its role in early-stage coronary artery disease management. The segment’s growth has been influenced by rising health screening programs and increased diagnosis of isolated coronary artery blockages, which are managed more effectively with single graft interventions.

Coronary Artery Bypass Grafts Market Analysis By Procedure

Minimally invasive surgical advancements have enabled the safer execution of single bypass procedures, especially in outpatient or short-stay hospital settings. Demand has also been supported by aging populations experiencing early cardiac symptoms that require less extensive revascularization.

Adoption has further been encouraged by lower procedural risk, quicker recovery, and reduced cost burden compared to multi-vessel procedures. Additionally, single CABG is often recommended for high-risk patients where complex surgeries are contraindicated.

Hospitals Dominate the Market Due to Advanced Surgical Infrastructure and Multidisciplinary Expertise

Hospitals have emerged as the leading end-user segment, accounting for 49.0% of the revenue share in 2025. This dominance has been attributed to the availability of advanced cardiovascular surgical infrastructure, including hybrid operating rooms, robotic systems, and post-operative intensive care units.

Most coronary artery bypass procedures continue to be centralized in hospital settings due to the need for comprehensive pre-operative diagnostics and high-acuity recovery care. Increased patient admissions, higher surgical throughput, and integrated insurance reimbursements have further consolidated hospital dominance. Government investments in cardiac care programs and hospital accreditation systems have also enhanced patient trust and procedural uptake, sustaining the segment's leadership position.

Challenges and Opportunities

Challenges

Increasing Preference for Percutaneous Coronary Interventions (PCI) Creating Barrier in Product Adoption

One of the greatest challenges facing the CABG market is the rise in preference for percutaneous coronary interventions (PCI), including angioplasty and drug-eluting stents (DES). PCI procedures are minimally invasive, involve shorter periods of recovery, and are commonly less expensive, thus becoming the first preference of most patients and cardiologists.

A second major challenge is the prohibitive cost of CABG procedures. The requirement of specialized surgical teams, sophisticated hospital facilities, and post-operative management renders CABG a costly mode of treatment, especially in low- and middle-income countries. Even in industrialized countries, insurance restrictions and differences in reimbursement policies influence patient accessibility.

Secondarily, post-surgical complications involving graft failure, infections, and stroke risk concern patients and doctors alike. Late venous graft durability is an ongoing problem and, therefore, more preference goes towards the arterial grafts requiring more advanced operative skills.

Opportunities

Growing Interest in Robotic-Assisted CABG and Hybrid Revascularization Procedures Creating Opportunities for the Coronary Artery Bypass Graft Industry

Robotic-assisted coronary artery bypass grafting (CABG) and hybrid revascularization surgeries are transforming the management of advanced coronary artery disease (CAD). Robotic-assisted CABG is a minimally invasive surgical method that employs robotic systems to execute extremely accurate graft placements, minimizing trauma, shortening recovery periods, and enhancing surgical results.

Hybrid revascularization, which uses both CABG and PCI in conjunction, has been implemented for its individualized delivery aimed at maximizing the results in terms of the patient, with an appeal specifically in those cases when open-heart surgery may be inapplicable or insufficient due to risks to the patient.

Growing use of robotic-assisted methods and hybrid surgery is boosting demand for sophisticated operating equipment, robot systems, and specialized grafts. Cardiac centers and hospitals are deploying robotic platforms and training initiatives to increase their capabilities in minimally invasive CABG, thereby increasing the market for associated medical devices. Further, with more clinical trials supporting long-term advantages of these procedures, physician confidence and patient preference for these procedures are also on the rise.

This trend is presenting considerable sales prospects for medical technology firms producing robotic surgical systems, anastomotic devices, and bioengineered grafts, putting them in a position to take advantage of the increased move toward novel CABG solutions.

Brief Market Overview

From 2020 to 2024, the coronary artery bypass graft (CABG) market has witneed consistent growth with increasing incidence of coronary artery disease (CAD), a growing aging world population, and lifestyle-related risk factors like obesity, diabetes, and hypertension. Technology evolution, like off-pump CABG procedures and minimally invasive surgical methods, enhanced patient outcomes and shortened recovery times.

But the growing popularity of percutaneous coronary interventions (PCI), including stenting, was challenging conventional CABG procedures. Excessive procedural cost and complications after surgery were the major challenges.

Coming into 2025 to 2035, market developments will be led by innovation in bioengineered grafts, AI-powered surgical planning, and robotic-assisted bypass. Regulatory infrastructures will find ways to embrace improvements in tissue-engineered grafts and minimal-access CABG technologies.

Rising access to healthcare in developing nations and increased government initiatives for treating cardiovascular disease will lead to expanding market opportunities. Sustainability will involve reducing environmental footprints through the use of biodegradable graft material and efficient energy-using operating room technology. Regionalization of production for medical devices will enhance supply chain resilience as well as availability of quality graft materials.

Country Wise Analysis

United States

Revolutionary technology is fuelling the growth of the United States CABG market. Cardiovascular diseases (CVD), particularly Coronary artery disease (CAD), continues to be the leading cause of death in many countries. Growing CABG need is also driven by demographic changes related to aging population, obesity, and increasing prevalence rates of diabetes.

Technological evolution including off-pump and minimally invasive coronary artery bypass (MIDCAB) has not only ushered greater care for the patient with lesser postoperative complications and quicker recovery. Dominant firms, such as Medtronic and Edwards Lifesciences, in the medical device industry fuel innovation in graft materials and instruments.

Market Growth Factors

  • High Incidence of Cardiovascular Diseases - CAD is still the most common cause of death, which requires CABG procedures.
  • Aging Population - Older patients are more at risk for multivessel coronary artery blockages, making surgery more required.
  • Improved Surgical Methods - Techniques in robotic and minimally invasive CABG enhance patient care.
  • Strong Healthcare Infrastructure - Well-staffed hospitals and talented surgeons spur market growth.
  • Presence of Leading Industry Players - Key manufacturers introduce high-quality grafts and advanced surgical tools.
Country CAGR (2025 to 2035)
United States 1.4%

Germany

Germany's industry outlook remains steady, supported by the healthcare system, advanced surgical department and increasingly adopted medical study. Cardiovascular disease is an enormous public health problem, and more patients require surgery. Hybrid revascularization procedures, combining CABG and PCI, are gaining popularity and improving patient's outcomes.

Germany is also leading the way in robotic-assisted and endoscopic CABG procedures, minimizing invasiveness and hospitalization. Government health policies and reimbursement schemes guarantee access to high-quality surgical procedures, further fueling market growth.

Market Growth Factors

  • Aging Population - One of Europe's oldest populations exists in Germany, generating demand for heart surgeries.
  • Strong Research and Innovation - Germany is a pioneer in developing robotic-assisted and endoscopic CABG procedures.
  • Advanced Healthcare System - CABG adoption is facilitated by top-of-the-line hospitals and cardiac centers.
  • Government Support and Reimbursement Policies - Positive funding improves access to surgical procedures for patients.
  • Increased Incidences of Severe CAD - Cases involving multi-vessel disease require operative interventions such as CABG.
Country CAGR (2025 to 2035)
Germany 1.8%

India

India's CABG market is reporting strong growth due to a rise in cardiovascular diseases and healthcare awareness. India has one of the highest CAD burdens globally with more than 60 million people suffering from heart disease. India has experienced rapid growth in cardiac specialty hospitals and the use of advanced surgical methods such as beating-heart surgery and off-pump CABG.

Affordability of medical care relative to Western nations has also established India as a medical tourism destination for foreign patients who are looking for high-quality yet affordable CABG procedures. Efforts by the government to increase access to healthcare, including Ayushman Bharat, are rendering advanced cardiac interventions more affordable for poor populations.

Market Growth Factors

  • Increasing CAD Cases - India has one of the highest heart disease burdens in the world.
  • Expansion of Cardiac Specialty Hospitals - Additional hospitals increase patient access to CABG.
  • Medical Tourism Growth - India's low cost appeals to foreign patients for cardiovascular operations.
  • Government Healthcare Schemes - Initiatives such as Ayushman Bharat enhance the availability of CABG.
  • Adoption of New Surgical Techniques - Beating-heart surgery and off-pump CABG decrease complications.
Country CAGR (2025 to 2035)
India 6.7%

China

The growth of CABG in China is rapid, owing primarily to the rising cases of cardiovascular disorder in China resulting from increased urbanization, physical inactivity, and smoking. Due to its population of more than 330 million patients with cardiovascular diseases, China has the largest global needs for cardiac interventional therapy.

The government has been putting significant financial resources into the health care infrastructure, and as a direct outcome the count of hospitals which can perform CABG surgery has grown Chinese medical institutions and scientists have also worked together with overseas companies to implement new forms of surgery, such as minimally invasive and robot-assisted CABG. In spite of these developments, inequality in access to healthcare between rural and urban areas and the affordability of surgery continue to be issues.

Market Growth Drivers

  • High Prevalence of Cardiovascular Diseases - Rising numbers of CAD require surgery.
  • Government Investment in Healthcare - Increase in cardiac surgery centers enhances availability of CABG.
  • Urbanization and Changes in Lifestyle - Sedentary lifestyle is the cause of increased incidence of CAD.
  • Global Partnerships - Collaborations with international medical firms bring cutting-edge CABG methods.
  • Middle-Class Expansion and Private Healthcare Growth - Greater affordability fuels CABG uptake.
Country CAGR (2025 to 2035)
China 5.9%

Brazil

The Brazil CABG market is likely to grow steadily during the forthcoming years, owing to the increasing prevalence of cardiovascular diseases, burgeoning healthcare expenditure, and improved surgical infrastructure in the territory. The country has experienced an uninterrupted increase in cases of CAD due to widespread obesity, hypertension, and diabetes.

The growth of the market is driven by increased government initiatives in improving cardiac care through more public hospital facilities and dedicated heart centers, etc. Also, private hospitals are making investments to upgrade the surgery facilities and use for minimally invasive way for Coronary artery bypass grafting. Economic inequalities and restricted access to sophisticated care in rural areas are creating hurdles.

Market Growth Drivers

  • High Incidence of CAD - Increasing levels of obesity and hypertension fuel demand for CABG.
  • Government Healthcare Investments - Public hospital expansion enhances cardiac care availability.
  • Expansion of Private Healthcare Sector - Investment in high-tech operating rooms fuels market growth.
  • Use of Minimally Invasive CABG - Less invasive procedures lower patient recovery times.
  • Expanding Middle-Class Population - More patients can afford advanced cardiac treatments.
Country CAGR (2025 to 2035)
Brazil 1.1%

Competitive Outlook

The coronary artery bypass graft (CABG) market is growing on account of rising cases of cardiovascular diseases, growing geriatric population, and expansion of minimally invasive surgical techniques.

Some of the key factors of competitive advantage for the market players are focusing on the new graft materials development, expanding in international markets and conducting studies for improved treatment outcomes. The market is very competitive with established medical device players and new companies launching next-generation CABG solutions.

Key Company Insights

Medtronic plc (27.7%)

Medtronic is building its presence in emerging economies by enhancing distribution networks and local partnerships with healthcare providers. It is also making investments in advanced bioengineered grafts for better long-term patency and lower risks of restenosis. Medtronic's value-based healthcare model focus enables hospitals to implement its CABG solutions by providing flexibility in pricing and reimbursement models.

Furthermore, Medtronic is combining machine learning algorithms with surgical planning software to optimize accuracy and anticipate patient results. These tactics individually place the firm at the forefront of traditional as well as robot-assisted CABG operations.

Terumo Corp (17.0%)

Terumo is concentrating on enlarging its portfolio of offerings in the form of high-performing surgical grafts and superior cardiopulmonary bypass technology. The firm is also investing in localized Asian and European manufacturing and R&D facilities to support low-cost production and faster regulatory clearances.

Incorporating nanotechnology coatings into its grafts, Terumo seeks to enhance biocompatibility and minimize thrombosis risk. The firm is further focusing on surgeon training programs and collaboration with medical institutions to drive the use of its minimally invasive CABG solutions in high-growth geographies.

Guidant Group (9.1%)

Guidant Group is utilizing its robotic-assisted CABG expertise by adding AI-powered navigation systems to further improve procedural precision. The firm is bolstering its clinical trial pipeline to establish the long-term effectiveness of hybrid revascularization as a superior alternative to standard CABG.

Guidant is also increasing hospital collaborations in North America and Europe to drive combined treatment models combining CABG and PCI. Through regulatory clearances for new anastomotic devices, Guidant is strengthening product differentiation and market penetration.

Getinge AB (9.3%)

Getinge is fueling growth through strategic acquisitions in the cardiovascular segment, broadening its expertise in CABG-related technologies. The company is also creating automated perfusion systems to improve patient safety in on-pump procedures. Getinge is investing in sutureless grafting solutions, minimizing surgical complexity and enhancing procedural efficiency.

With a focus on sustainability and affordable healthcare solutions, the firm is customizing its CABG solutions for cost-conscious hospitals. Getinge is also enhancing its after-sales service and training solutions to facilitate long-term use of its surgical systems.

Other Key Players (48.1% Combined)

A number of other companies are major contributors to the coronary artery bypass graft market through advanced cardiovascular technologies and increased distribution networks. They include:

  • Vitalitec International, Inc.
  • Novadaq Technologies Inc.
  • KARL STORZ GmbH & Co. K.G.
  • Edwards Lifesciences
  • Genesee Biomedical Inc.
  • Others

With the demand for coronary artery bypass graft procedures growing unabated, firms are focusing on technological innovations, regulatory clearances, and strategic partnerships to reinforce their market positions and enhance surgical outcomes.

Coronary Artery Bypass Grafts Market by Top Investment Segments

The market is segmented based on technology, procedure, end user, and region.

By Technology:

the market is segmented into Off-Pump CABG, On-Pump CABG, and Others.

By Procedure:

the market is segmented into Single-CABG surgery, Double-CABG surgery, Triple-CABG surgery, Quadruple-CABG surgery, and others.

By End User:

the market is segmented into Hospitals, Academic & Research Institutes, and Independent Cardiology Centers.

By Region:

Regionally, the coronary artery bypass graft market is analysed across North America, Latin America, Western Europe, Eastern Europe, East Asia, South Asia & Pacific, and the Middle East & Africa.

Table of Content

  1. Executive Summary
  2. Industry Introduction, including Taxonomy and Market Definition
  3. Market Trends and Success Factors, including Macro-Economic Factors, Market Dynamics, and Recent Industry Developments
  4. Global Market Demand Analysis 2020 to 2024 and Forecast 2025 to 2035, including Historical Analysis and Future Projections
  5. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035
    • By Technology
    • By Procedure
    • By End User
    • By Region
  6. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Technology
    • Off-pump CABG
    • On-pump CABG
    • Others
  7. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Procedure
    • Single CABG surgery
    • Double CABG surgery
    • Triple CABG surgery
    • Quadruple CABG surgery
    • Others
  8. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By End User
    • Hospitals
    • Cardiology Clinics
    • Research Institutes
    • Others
  9. Global Market Analysis 2020 to 2024 and Forecast 2025 to 2035, By Region
    • North America
    • Latin America
    • East Asia
    • South Asia and Pacific
    • Western Europe
    • Eastern Europe
    • Middle East and Africa
  10. North America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  11. Latin America Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  12. East Asia Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  13. South Asia & Pacific Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  14. Western Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  15. Eastern Europe Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  16. Middle East and Africa Sales Analysis 2020 to 2024 and Forecast 2025 to 2035, By Key Segments and Countries
  17. Sales Forecast 2025 to 2035 By Technology, By Procedure and By End User for 30 Countries
  18. Competition Outlook, including Market Structure Analysis, Company Share Analysis By Key Players, and Competition Dashboard
  19. Company Profile
    • Medtronic
    • TERUMO CORPORATION
    • Guidant Group
    • Getinge AB
    • Vitalitec International, Inc.
    • Novadaq Technologies Inc.
    • Others
    • KARL STORZ GmbH & Co. K.G.
    • Edwards Lifesciences
    • Genesee Biomedical Inc.
    • Sorin Group

List of Tables

  • Table 1: Global Market Value (USD Million) Forecast by Region, 2020 to 2035
  • Table 2: Global Market Volume (Units) Forecast by Region, 2020 to 2035
  • Table 3: Global Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 4: Global Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 5: Global Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 6: Global Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 7: Global Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 8: Global Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 9: North America Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 10: North America Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 11: North America Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 12: North America Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 13: North America Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 14: North America Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 15: North America Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 16: North America Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 17: Latin America Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 18: Latin America Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 19: Latin America Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 20: Latin America Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 21: Latin America Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 22: Latin America Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 23: Latin America Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 24: Latin America Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 25: Western Europe Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 26: Western Europe Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 27: Western Europe Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 28: Western Europe Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 29: Western Europe Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 30: Western Europe Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 31: Western Europe Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 32: Western Europe Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 33: East Asia Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 34: East Asia Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 35: East Asia Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 36: East Asia Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 37: East Asia Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 38: East Asia Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 39: East Asia Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 40: East Asia Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 41: South Asia & Pacific Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 42: South Asia & Pacific Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 43: South Asia & Pacific Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 44: South Asia & Pacific Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 45: South Asia & Pacific Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 46: South Asia & Pacific Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 47: South Asia & Pacific Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 48: South Asia & Pacific Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 49: Eastern Europe Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 50: Eastern Europe Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 51: Eastern Europe Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 52: Eastern Europe Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 53: Eastern Europe Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 54: Eastern Europe Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 55: Eastern Europe Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 56: Eastern Europe Market Volume (Units) Forecast by End User, 2020 to 2035
  • Table 57: Middle East & Africa Market Value (USD Million) Forecast by Country, 2020 to 2035
  • Table 58: Middle East & Africa Market Volume (Units) Forecast by Country, 2020 to 2035
  • Table 59: Middle East & Africa Market Value (USD Million) Forecast by Product, 2020 to 2035
  • Table 60: Middle East & Africa Market Volume (Units) Forecast by Product, 2020 to 2035
  • Table 61: Middle East & Africa Market Value (USD Million) Forecast by Procedure, 2020 to 2035
  • Table 62: Middle East & Africa Market Volume (Units) Forecast by Procedure, 2020 to 2035
  • Table 63: Middle East & Africa Market Value (USD Million) Forecast by End User, 2020 to 2035
  • Table 64: Middle East & Africa Market Volume (Units) Forecast by End User, 2020 to 2035

List of Figures

  • Figure 1: Global Market Volume (Units) Forecast 2020 to 2035
  • Figure 2: Global Market Pricing Analysis
  • Figure 3: Global Market Value (USD Million) Forecast 2020 to 2035
  • Figure 4: Global Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 5: Global Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 6: Global Market Attractiveness Analysis by Product
  • Figure 7: Global Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 8: Global Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 9: Global Market Attractiveness Analysis by Procedure
  • Figure 10: Global Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 11: Global Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 12: Global Market Attractiveness Analysis by End User
  • Figure 13: Global Market Value (USD Million) Share and BPS Analysis by Region, 2025 and 2035
  • Figure 14: Global Market Y-o-Y Growth Comparison by Region, 2025 to 2035
  • Figure 15: Global Market Attractiveness Analysis by Region
  • Figure 16: North America Market Incremental $ Opportunity, 2025 to 2035
  • Figure 17: Latin America Market Incremental $ Opportunity, 2025 to 2035
  • Figure 18: Western Europe Market Incremental $ Opportunity, 2025 to 2035
  • Figure 19: East Asia Market Incremental $ Opportunity, 2025 to 2035
  • Figure 20: South Asia & Pacific Market Incremental $ Opportunity, 2025 to 2035
  • Figure 21: Eastern Europe Market Incremental $ Opportunity, 2025 to 2035
  • Figure 22: Middle East & Africa Market Incremental $ Opportunity, 2025 to 2035
  • Figure 23: North America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 24: North America Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 25: North America Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 26: North America Market Attractiveness Analysis by Product
  • Figure 27: North America Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 28: North America Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 29: North America Market Attractiveness Analysis by Procedure
  • Figure 30: North America Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 31: North America Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 32: North America Market Attractiveness Analysis by End User
  • Figure 33: Latin America Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 34: Latin America Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 35: Latin America Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 36: Latin America Market Attractiveness Analysis by Product
  • Figure 37: Latin America Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 38: Latin America Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 39: Latin America Market Attractiveness Analysis by Procedure
  • Figure 40: Latin America Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 41: Latin America Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 42: Latin America Market Attractiveness Analysis by End User
  • Figure 43: Western Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 44: Western Europe Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 45: Western Europe Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 46: Western Europe Market Attractiveness Analysis by Product
  • Figure 47: Western Europe Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 48: Western Europe Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 49: Western Europe Market Attractiveness Analysis by Procedure
  • Figure 50: Western Europe Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 51: Western Europe Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 52: Western Europe Market Attractiveness Analysis by End User
  • Figure 53: East Asia Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 54: East Asia Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 55: East Asia Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 56: East Asia Market Attractiveness Analysis by Product
  • Figure 57: East Asia Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 58: East Asia Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 59: East Asia Market Attractiveness Analysis by Procedure
  • Figure 60: East Asia Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 61: East Asia Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 62: East Asia Market Attractiveness Analysis by End User
  • Figure 63: South Asia & Pacific Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 64: South Asia & Pacific Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 65: South Asia & Pacific Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 66: South Asia & Pacific Market Attractiveness Analysis by Product
  • Figure 67: South Asia & Pacific Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 68: South Asia & Pacific Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 69: South Asia & Pacific Market Attractiveness Analysis by Procedure
  • Figure 70: South Asia & Pacific Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 71: South Asia & Pacific Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 72: South Asia & Pacific Market Attractiveness Analysis by End User
  • Figure 73: Eastern Europe Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 74: Eastern Europe Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 75: Eastern Europe Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 76: Eastern Europe Market Attractiveness Analysis by Product
  • Figure 77: Eastern Europe Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 78: Eastern Europe Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 79: Eastern Europe Market Attractiveness Analysis by Procedure
  • Figure 80: Eastern Europe Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 81: Eastern Europe Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 82: Eastern Europe Market Attractiveness Analysis by End User
  • Figure 83: Middle East & Africa Market Value Share and BPS Analysis by Country, 2025 and 2035
  • Figure 84: Middle East & Africa Market Value Share and BPS Analysis by Product, 2025 and 2035
  • Figure 85: Middle East & Africa Market Y-o-Y Growth Comparison by Product, 2025 to 2035
  • Figure 86: Middle East & Africa Market Attractiveness Analysis by Product
  • Figure 87: Middle East & Africa Market Value Share and BPS Analysis by Procedure, 2025 and 2035
  • Figure 88: Middle East & Africa Market Y-o-Y Growth Comparison by Procedure, 2025 to 2035
  • Figure 89: Middle East & Africa Market Attractiveness Analysis by Procedure
  • Figure 90: Middle East & Africa Market Value Share and BPS Analysis by End User, 2025 and 2035
  • Figure 91: Middle East & Africa Market Y-o-Y Growth Comparison by End User, 2025 to 2035
  • Figure 92: Middle East & Africa Market Attractiveness Analysis by End User
  • Figure 93: Global Market - Tier Structure Analysis
  • Figure 94: Global Market - Company Share Analysis

Frequently Asked Questions

What was the overall size of the Coronary Artery Bypass Grafts Market in 2025?

The overall market size for coronary artery bypass grafts market was USD 18,700.6 million in 2025.

How big is the Coronary Artery Bypass Grafts Market expected in 2035?

The coronary artery bypass grafts market is expected to reach USD 24,887.3 million in 2035.

What will drive the demand for Coronary Artery Bypass Grafts Market during the forecast period?

Rising prevalence of infectious diseases, cancer, and autoimmune disorders has significantly increased the demand for Western blot assays in clinical diagnostics.

List the top 5 Key players of the Coronary Artery Bypass Grafts Market?

The top key players that drives the development of coronary artery bypass graft market are Medtronic, Terumo Corporation, Guidant Group, Getinge AB, and Vitalitec International, Inc.

Which segment in technology is expected to lead in Coronary Artery Bypass Grafts Market?

On-pump CABG by technology is coronary artery bypass graft market is expected to command significant share over the assessment period.

Explore Similar Insights

Future Market Insights

Coronary Artery Bypass Grafts Market